Hepatitis b vaccine
Intervention2 papers2 findings
- Humans1
Outcomes
1P-TAU181
downin humans1Very low certainty
1 study
P-TAU181
downin humans1Very low certainty
Hepatitis b vaccine decreases P-TAU181 in humans.
Humansin AD biomarker panel
Adult Vaccination History and Plasma Biomarker Signatures in the Asymptomatic PREVENT-AD Cohort · medRxiv · 27 Aug 2026 · Preprint
Associations
1Hepatocellular carcinoma
downin humans1High certainty
1 study
Hepatocellular carcinoma
downin humans1High certainty
Hepatitis b vaccine lowers the risk of hepatocellular carcinoma in humans (65% reduction, IRR 0.35, 95% CI: 0.26-0.47).
Review
Global impact of hepatitis B vaccination on the risk of hepatocellular carcinoma: a systematic review and meta-analysis · Journal of gastrointestinal oncology · 8 Jul 2026
Latest
2Journal of Gastrointestinal OncologyReview